Formula: | C21H25N5O2 |
Molecular Weight: | 379.46 |
Rotatable Bond Donors: | 4 |
clogP: | 3.56 |
Topological Polar Surface Area: | 76.16 |
Lipinski's RO5: | MW: 379.46 HBA: 7 HBD: 1 RB: 4 LogP: 3.56 |
Rule of Three: | MW: 379.46 HBA: 7 HBD: 1 RB: 4 LogP: 3.56 |
|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC220966210 | 1.0 | ZINC220966210 RDKit 3D 28 32 0 0 0 0 0 0 0 0999 V2000 -6.1951 -2.0285 1.4217 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.6945 -0.6277 1.1696 C 0 0 1 0 0 0 0 0 0 0 0 0 -4.2146 -0.6823 0.7945 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.7376 0.6517 0.4376 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.3829 0.6871 0.0796 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4782 -0.1479 0.7125 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1523 -0.0305 0.3483 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8495 -0.9028 0.9703 C 0 0 0 0 0 0 0 0 0 0 0 0 0.5066 -1.8516 1.8637 N 0 0 0 0 0 0 0 0 0 0 0 0 1.6695 -2.4273 2.2007 N 0 0 0 0 0 0 0 0 0 0 0 0 2.7613 -1.9083 1.5726 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1151 -2.2368 1.6598 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9878 -1.4908 0.8627 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5291 -0.4751 0.0264 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4912 0.1804 -0.7041 O 0 0 0 0 0 0 0 0 0 0 0 0 5.0344 1.2230 -1.5870 C 0 0 0 0 0 0 0 0 0 0 0 0 4.6831 2.5079 -0.9297 C 0 0 0 0 0 0 0 0 0 0 0 0 4.3667 0.8289 -2.8739 C 0 0 0 0 0 0 0 0 0 0 0 0 5.7817 1.3152 -2.8877 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1664 -0.1710 -0.0372 C 0 0 0 0 0 0 0 0 0 0 0 0 2.2636 -0.9037 0.7532 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2845 0.8552 -0.5687 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.6610 1.6288 -1.1117 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.9718 1.5897 -0.8308 N 0 0 0 0 0 0 0 0 0 0 0 0 -4.5800 1.3298 -0.5447 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.0427 1.2811 -0.1087 C 0 0 1 0 0 0 0 0 0 0 0 0 -6.9055 1.8735 -1.1953 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.4743 -0.0680 0.1071 O 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 6 2 3 1 0 3 4 1 0 4 5 1 0 5 6 2 0 6 7 1 0 7 8 1 0 8 9 2 0 9 10 1 0 10 11 1 0 11 12 2 0 12 13 1 0 13 14 2 0 14 15 1 0 15 16 1 0 16 17 1 0 16 18 1 0 18 19 1 0 14 20 1 0 20 21 2 0 7 22 2 0 22 23 1 0 23 24 2 0 4 25 1 0 25 26 1 0 26 27 1 6 26 28 1 0 28 2 1 0 24 5 1 0 21 8 1 0 21 11 1 0 19 16 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |